Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"
J Clin Endocrinol Metab
.
2022 Apr 19;107(5):e2215-e2216.
doi: 10.1210/clinem/dgab879.
Authors
Paul S Thornton
1
,
Aristides K Maniatis
2
,
Elena Aghajanova
3
,
Elena Chertok
4
,
Zhengning Lin
5
,
Wenjie Song
5
,
Eva Dam Christoffersen
6
,
Vibeke Miller Breinholt
6
,
Elene Giorgadze
7
,
Maria Korpal-Szczyrska
8
,
Paul L Hofman
9
,
David B Karpf
5
,
Aimee D Shu
5
,
Michael Beckert
6
Affiliations
1
Cook Children's Medical Center, Fort Worth, TX 76104, USA.
2
Rocky Mountain Pediatric Endocrinology, Centennial, CO 80112, USA.
3
Yerevan State Medical University, Yerevan 0025, Armenia.
4
Voronezh State Medical University, 394036 Voronezh, Russia.
5
Ascendis Pharma, Inc., Palo Alto, CA 94304, USA.
6
Ascendis Pharma A/S, 2900 Hellerup, Denmark.
7
LTD National Institute of Endocrinology, 0159 Tbilisi, Georgia.
8
Medical University of Gdansk, 80-210 Gdansk, Poland.
9
Liggins Institute, University of Auckland, Auckland 1023, New Zealand.
PMID:
34915563
PMCID:
PMC9016423
DOI:
10.1210/clinem/dgab879
No abstract available
Publication types
Letter
Comment
MeSH terms
Body Height
Child
Dwarfism, Pituitary* / drug therapy
Growth Hormone
Humans
Substances
Growth Hormone